This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Dr. Aileen Marty, Infectious Disease ...

The packing and shipping of a third COVID-19 vaccine approved for use in the U.S. is underway. Johnson & Johnson’s single-dose shot will start going into Americans’ arms in a matter of days. Nearly 4 ...

Moderna COVID-19 vaccines were associated with a threefold increased risk of chronic urticaria and nearly fourfold increased risk of other types of urticaria compared to expected rates.

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine makers ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in the ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC vaccine advisory meeting. At Wednesday’s close, Novavax closed down 0.2% at ...